National Institutes of Health (NIH)

NIH begins first-in-human trial of a universal influenza vaccine candidate

Investigational vaccine designed to provide broad, durable protection from flu.

Health, substance use professionals must work together to thwart public health crisis.

Small NIH clinical trial conducted in partnership with AstraZeneca.

Cells use RNA to communicate; researchers may be able to translate this information into clinical applications.

Experts in immunology, virology, epidemiology, and vaccine development detail efforts to improve seasonal influenza vaccines.

An NIH-funded review examined billing data from over 500,000 healthcare visits.

Previous studies have linked exposure to common air pollutants in pregnancy to low birthweight, preterm birth and stillbirth.

EBV is herpesvirus that causes infectious mononucleosis and is associated with certain cancers.

Small-scale, NIH-led clinical study offers early hope for developing a treatment.

NIH-supported study sheds light on the neural mechanisms underlying remission of depression.